Sermorelin Acetate growth hormone
Sermorelin Acetate growth hormone releasing hormone therapy is less expensive or about 70% of the cost of genetically engineered recombinant human growth hormone therapy because of the high cost of genetically engineered medication.
- It is medically preferable and safer for the human body to increase the level of human growth hormone and IGF-1 naturally within its own capacity by the use of Sermorelin growth hormone releasing hormone, rather than though the injection of exogenous genetically engineered human growth hormone. This is because the body’s endocrine system safely regulates the amount of additional human growth hormone secreted by the pituitary gland as a consequence of exogenous injections of Sermorelin growth hormone releasing hormone stimulating pituitary production of additional human growth hormone. In contrast, there is no limitation or regulation of the volume of genetically engineered human growth hormone that may be injected by a patient into the body with the resulting potential adverse consequences of high and excessive levels of human growth hormone. Risks include the unsafe and excessive growth or internal organs. Medical research has not found that the body’s endocrine system provides a certain or safe regulation for exogenous source of injected human growth hormone not produced naturally by the body’s pituitary gland. Moreover, possible adverse effects of the use of injected genetically engineered human growth hormone are unknown.